Cyclosporine: SANG has finished treating the healthy volunteers in its bioequivalence trial

SangStat Medical Corp. (SANG), Menlo Park, Calif. Product: Cyclosporine Indication: Chronic immunosuppression in transplant recipients to prevent organ rejection Status: SANG has finished treating the...